# FDA Inspection 1292894 - RxCrossroads 3PL LLC - November 20, 2025

Source: https://www.keypedia.com/records/fda_inspections/rxcrossroads-3pl-llc/02b9a53d-e041-4df7-986b-f9aaa21ef9a5
Source feed: FDA_Inspections

> FDA Inspection 1292894 for RxCrossroads 3PL LLC on November 20, 2025. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1292894
- Company Name: RxCrossroads 3PL LLC
- Inspection Date: 2025-11-20
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1292894 - 2025-11-20](https://www.keypedia.com/records/fda_inspections/rxcrossroads-3pl-llc/13f8c360-c540-4a90-9ee8-3b5e34549562)
- [FDA Inspection 1068442 - 2018-10-04](https://www.keypedia.com/records/fda_inspections/rxcrossroads-3pl-llc/cc9e3a46-b45c-4a92-9213-dbd82bdf257b)
- [FDA Inspection 830817 - 2013-05-09](https://www.keypedia.com/records/fda_inspections/rxcrossroads-3pl-llc/c908e973-569c-4b04-a3cd-2c717d78a6e5)

Company: https://www.keypedia.com/companies/rxcrossroads-3pl-llc/94dbab9e-d27d-41b9-a1f5-fd564a64ab53

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d